Instead, the tPA/PAI‐1 pathway can be targeted by pharmacological agents,54 a strategy that has been already adopted in other types of diseases such as diabetic nephropathy114 and fibrosis.115 However, there is a need to explore the effects of these agents on BDNF expression in healthy and AD subjects. Here, BDNF is linked to Alzheimer disease.